Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Koen Deschepper"'
Autor:
Jolien Van den Bossche, Maxime De Laere, Koen Deschepper, Paul Germonpré, Yvan Valcke, Jan Lamont, Barbara Stein, Kirsten Van Camp, Charlotte Germonpré, Griet Nijs, Ella Roelant, Sébastien Anguille, Eva Lion, Zwi Berneman
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0307204 (2024)
Malignant pleural mesothelioma (MPM) is an aggressive cancer with a very poor prognosis. Recently, immune checkpoint inhibition (ICI) has taken center stage in the currently ongoing revolution that is changing standard-of-care treatment for several m
Externí odkaz:
https://doaj.org/article/0fc25e2cc8ca4f028c79ed96487bc0db
Autor:
Laure Sorber, Karen Zwaenepoel, Koen De Winne, Kaat Van Casteren, Elien Augustus, Julie Jacobs, Xiang Hua Zhang, Daniëlla Galdermans, Els De Droogh, Anneke Lefebure, Ann-Marie Morel, Erika Saenen, Frédérique Bustin, Ingel Demedts, Ulrike Himpe, Thierry Pieters, Paul Germonpré, Sofie Derijcke, Koen Deschepper, Jan P. Van Meerbeeck, Christian Rolfo, Patrick Pauwels
Publikováno v:
Cancers, Vol 10, Iss 9, p 290 (2018)
A multicenter study was performed to determine an optimal workflow for liquid biopsy in a clinical setting. In total, 549 plasma samples from 234 non-small cell lung cancer (NSCLC) patients were collected. Epidermal Growth Factor Receptor (EGFR) circ
Externí odkaz:
https://doaj.org/article/3d2d24e5088d4cc8ab397b2b98494751
Autor:
Anne Sibille, Frederique Bustin, Luciano Carestia, Gaetan Catala, Christophe Compère, Kristof Cuppens, Benoit Colinet, Stephanie Coulon, Nele De Brucker, Lore Decoster, Lynn Decoster, Ingel Demedts, Sofie Derijcke, Koen Deschepper, Danny Galdermans, Annelies Janssens, Sebahat Ocak, Christel Oyen, Karin Pat, Thierry Pieters, Vincent Pruniau, Veerle Surmont, Saar Vandekeere, Johan Vansteenkiste
Publikováno v:
Acta oncologica
Acta oncologica (Stockholm, Sweden), Vol. 61, no. 6, p. 773-776 (2022)
Acta oncologica (Stockholm, Sweden), Vol. 61, no. 6, p. 773-776 (2022)
Medical writing and editorial assistance were provided by Tim Ibbotson, PhD, of ApotheCom (Yardley, PA, USA) and funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. Statistical analysis was done by Herbert Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaa79d19a81a12ecdb48210dc208165b
Autor:
Lore Decoster, Karin Pat, Anne Sibille, Frederic Clinckart, Sofie Joris, Stéphane Holbrechts, Marc Lambrechts, Frederique Bustin, Denis Schallier, Laurence Jacqmin, Wim Demey, Hassan Rezaei Kalantari, Veerle Surmont, Koen Deschepper, Thierry Pieters, Jean-Charles Goeminne
Publikováno v:
Journal of geriatric oncology, Vol. 11, no. 5, p. 796-801 (2019)
Objectives To compare real life effectiveness and safety of nivolumab in patients with non-small cell lung cancer (NSCLC), according to age and Eastern Cooperative Group performance status (ECOG-PS). Methods We performed a retrospective analysis of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3684f3713e0b86cfe548b49b9f9c562
https://biblio.vub.ac.be/vubir/real-life-safety-and-effectiveness-of-nivolumab-in-older-patients-with-nonsmall-cell-lung-cancer-results-from-the-belgian-compassionate-use-program(2593922e-5a4d-49ac-b2b8-a9ff594edda4).html
https://biblio.vub.ac.be/vubir/real-life-safety-and-effectiveness-of-nivolumab-in-older-patients-with-nonsmall-cell-lung-cancer-results-from-the-belgian-compassionate-use-program(2593922e-5a4d-49ac-b2b8-a9ff594edda4).html
Autor:
Diether Lambrechts, Guy Berchem, Peter Vuylsteke, Sebahat Ocak, Marc Lambrechts, Sylvia De Brakeleer, Daniella Galdermans, Jacques De Greve, Lynn Decoster, Erik Teugels, Bram Boeckx, Lore Decoster, Thomas Van Brussel, Koen Deschepper, Patrick Alexander, Piet Vercauter, Rajendra Bahadur Shahi, Dominiek Smeets, Nadia Cappoen
Publikováno v:
International journal of cancer, Vol. 146, no. 11, p. 3207-3218 (2020)
Lung cancer is the number one cause of cancer-related death worldwide with cigarette smoking as its major risk factor. Although the incidence of lung cancer in never smokers is rising, this subgroup of patients is underrepresented in genomic studies
Publikováno v:
memo-Magazine of European Medical Oncology
This case shows that a tumor can present in an uncommon way. When dealing with pulmonary masses, tissue remains the most important issue. We present the case of a 71-year-old woman with a mass of more than 10 cm in the left lung. Pulmonary CT scan an
Autor:
Jan P. van Meerbeeck, Anneke Lefebure, Julie Jacobs, Koen Deschepper, Thierry Pieters, Erika Saenen, Laure Sorber, Ulrike Himpe, Ingel K. Demedts, Kaat Van Casteren, Frederique Bustin, Karen Zwaenepoel, Christian Rolfo, Xiang Hua Zhang, Els De Droogh, Sofie Derijcke, Patrick Pauwels, Paul Germonpré, Ann-Marie Morel, Koen De Winne, Daniella Galdermans, Elien Augustus
Publikováno v:
Cancers
Cancers, Vol 10, Iss 9, p 290 (2018)
Cancers, Vol. 10, no. 9, p. 290 [1-14] (2018)
Volume 10
Issue 9
Cancers, Vol 10, Iss 9, p 290 (2018)
Cancers, Vol. 10, no. 9, p. 290 [1-14] (2018)
Volume 10
Issue 9
A multicenter study was performed to determine an optimal workflow for liquid biopsy in a clinical setting. In total, 549 plasma samples from 234 non-small cell lung cancer (NSCLC) patients were collected. Epidermal Growth Factor Receptor (EGFR) circ
Autor:
Sofie Derijcke, Koen Deschepper, Thierry Pieters, Laure Sorber, Karen Zwaenepoel, Christian Rolfo, Ingel K. Demedts, J. Van Meerbeeck, Patrick Pauwels, Paul Germonpré
Publikováno v:
ESMO Open. 3:A410
Introduction A multicenter study was performed in Belgium to establish an optimal workflow for liquid biopsy, consisting of circulating cell-free tumour DNA (ctDNA) analysis. Material and methods EGFR ctDNA mutational analysis was performed on 549 pl
Publikováno v:
American Review of Respiratory Disease. 144:797-802
We studied the effects of aminophylline on respiratory muscle interaction during quiet breathing by measuring (1) changes in rib cage and abdominal cross-sectional area, (2) tidal volume, (3) abdominal and esophageal pressure, (4) diaphragm and paras
Autor:
Kurt Vandeurzen, Christophe Dooms, Jean Vandebroek, Paul Van den Brande, Koen Deschepper, Lionel Bosquée, Jean Pierre D'Odemont, Dany Galdermans, Nancy Dams, R. Deman, Alain Delobbe, Wim Van Kerckhoven, Kristiaan Nackaerts, Luc Siemons, Johan Vansteenkiste
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 40(2)
Background: We previously reported that treatment of patients with symptomatic advanced non-small cell lung cancer with single agent Gemcitabine (GEM) resulted in a superior clinical-benefit response rate (RR) compared to cisplatin-based combination